the critical steps for protein therapeutic potency assay development
Published 9 months ago • 110 plays • Length 34:33Download video MP4
Download video MP3
Similar videos
-
4:46
when to conduct analytical assays in novel protein therapeutic development
-
9:03
what is potency? an introduction
-
1:00:55
addressing potency assay development challenges
-
18:29
continuity of methods: characterizing protein therapeutic stability from developability assessment
-
45:29
development of potency assays for cell and gene therapy
-
22:35
strategic development of characterization and quality control programs for therapeutic peptides
-
1:03:21
applying a matrix approach for potency assay development for in vivo and ex vivo gene therapies
-
3:08
development of an in vitro potency assay of immune effector cell-mediated cytotoxicity and kinetics
-
43:35
advancing process efficiency for the end to end manufacturing of t cell immunotherapies
-
39:56
cho expression platform: the workhorse of protein expression in pharmaceutical industry
-
1:03:21
lunch & learn: how aav vectors are made
-
47:14
analytical ultracentrifugation for characterization of aav gene delivery vectors
-
23:10
biopharmaceutical formulation a journey from expression to patient
-
58:59
technology development tailored to address cell therapy manufacturing challenges
-
22:16
developability: evaluating specificity, immunogenicity, functionality, and manufacturability...
-
0:54
ai-based analysis of a t cell potency assay
-
1:10:58
developing methods for comparability studies of therapeutic monoclonal antibodies
-
20:38
inducible secretion with esetec: the solution for difficult-to-produce proteins
-
48:08
mab early development and critical considerations for commercialization success
-
20:19
manufacturing a recombinant retrovirus — downstream purification process development
-
23:35
gene therapy product analytics: where historical and modern techniques meet